How to supply EMA-approved COVID-19 vaccines to developing countries
Feature ArticlesLea Katharina Kunath, MSc • Ralf D. Hess, MSc, PhD • Andreas Bechthold, Reg-Pharm, PhD • Manfred Jung, Reg-Pharm, PhD
Biologics/ biosimilars/ vaccinesCoronavirus/COVID-19European Medicines Agency (EMA)GlobalHealth Authority meeting and communication strategySupply Chain Management